BioAge Labs (BIOA) Shares Outstanding (Diluted Average) (2023 - 2026)

BioAge Labs has disclosed Shares Outstanding (Diluted Average) across 4 years of filings, most recently posting $42.5 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $42.5 million, up 18.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.5 million (up 18.49% YoY), and the FY2025 annual result was $35.9 million, up 234.99% from the prior year.
• Shares Outstanding (Diluted Average) came in at $42.5 million for Q1 2026 at BioAge Labs, up from $35.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $42.5 million in Q1 2026 to a low of $1.7 million in Q3 2023.
• The 4-year median for Shares Outstanding (Diluted Average) is $10.7 million (2024), against an average of $18.8 million.
• Across the five-year window, Shares Outstanding (Diluted Average) jumped 2042.25% in 2025 and grew 18.49% in 2026, its largest moves.
• BioAge Labs' Shares Outstanding (Diluted Average) stood at $1.7 million in 2023, then soared by 541.23% to $10.7 million in 2024, then jumped by 234.99% to $35.9 million in 2025, then rose by 18.22% to $42.5 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $42.5 million (Q1 2026), $35.9 million (Q4 2025), and $35.9 million (Q3 2025), per Business Quant data.